Pulmovant is a Roivant-backed clinical-stage biotechnology company committed to transforming the lives of patients with pulmonary diseases. Pulmovant’s first investigational candidate, mosliciguat, is designed to…
Cookies?
A session cookie keeps you signed in. If you accept, we also use analytics cookies (Google Analytics and PostHog) to understand usage. Learn more
We couldn't check your fit for this role — add a CV to your profile to see it next time.